Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 3, Pages 689-698
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.1080/21645515.2015.1011022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro
- (2013) Petr Lokhov et al. Human Vaccines & Immunotherapeutics
- Universal cancer vaccine
- (2013) Petr G. Lokhov et al. Human Vaccines & Immunotherapeutics
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- A Heterogeneous In Vitro Three Dimensional Model of Tumour-Stroma Interactions Regulating Sprouting Angiogenesis
- (2012) Pedro Correa de Sampaio et al. PLoS One
- Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
- (2012) Petr G. Lokhov et al. Journal of Cancer
- Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence
- (2011) Elena E. Balashova et al. MOLECULAR & CELLULAR PROTEOMICS
- Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
- (2010) VE Shaw et al. Expert Review of Vaccines
- Whole tumor antigen vaccines
- (2010) Cheryl Lai-Lai Chiang et al. SEMINARS IN IMMUNOLOGY
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Cancer vaccination with telomerase peptide GV1001
- (2009) Jon Amund Kyte EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prioritization of cancer antigens: keeping the target in sight
- (2009) Joshua M Lang et al. Expert Review of Vaccines
- Comprehensive Profiling of the Cell Surface Proteome of Sy5Y Neuroblastoma Cells Yields a Subset of Proteins Associated with Tumor Differentiation
- (2009) Jacob Garcia et al. JOURNAL OF PROTEOME RESEARCH
- Efficient Isolation and Quantitative Proteomic Analysis of Cancer Cell Plasma Membrane Proteins for Identification of Metastasis-Associated Cell Surface Markers
- (2009) Rikke Lund et al. JOURNAL OF PROTEOME RESEARCH
- Cell proteomic footprint
- (2009) Petr Lokhov et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Molecular Characterization of Human Breast Tumor Vascular Cells
- (2008) Rajendra Bhati et al. AMERICAN JOURNAL OF PATHOLOGY
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
- (2008) Tanja D. de Gruijl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started